BRIEF-Catabasis Pharmaceuticals Says Board Approved Reduction In Company’S Workforce Of About 48%- SEC Filing

Reuters

07 Dec 2020

Dec 7 (Reuters) - Catabasis Pharmaceuticals Inc :

* CATABASIS PHARMACEUTICALS SAYS ON DECEMBER 4, BOARD APPROVED REDUCTION IN COMPANY’S WORKFORCE OF ABOUT 48%, TO A TOTAL OF 16 EMPLOYEES - SEC FILING

* CATABASIS PHARMACEUTICALS - EXPECTS RESTRUCTURING TO RESULT IN ABOUT $2.8 MILLION IN REDUCED ANNUALIZED WORKFORCE EXPENSES ONCE PLAN FULLY IMPLEMENTED

* CATABASIS PHARMACEUTICALS - CURRENTLY ESTIMATES TO INCUR CHARGES FOR ONE-TIME TERMINATION BENEFITS IN CONNECTION WITH RESTRUCTURING OF ABOUT $1 MILLION IN Q4

* CATABASIS PHARMACEUTICALS SAYS EXPECTS TO COMPLETE THE REDUCTION IN WORKFORCE BY THE END OF THE FOURTH QUARTER OF 2020

Source text for Eikon: [ Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2089011144"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2089011144\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2089011144?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2020-12-07 21:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2089011144","market":"us","top_or_hot":-1,"title":"BRIEF-Catabasis Pharmaceuticals Says Board Approved Reduction In Company’S Workforce Of About 48%- SEC Filing","media":"Reuters","content":"<html><body><p>Dec 7 (Reuters) - Catabasis Pharmaceuticals Inc   :</p><p>   * CATABASIS PHARMACEUTICALS SAYS ON DECEMBER 4, BOARD APPROVED REDUCTION IN COMPANY’S WORKFORCE OF ABOUT 48%, TO A TOTAL OF 16 EMPLOYEES - SEC FILING</p><p>   * CATABASIS PHARMACEUTICALS - EXPECTS RESTRUCTURING TO RESULT IN ABOUT $2.8 MILLION IN REDUCED ANNUALIZED WORKFORCE EXPENSES ONCE PLAN FULLY IMPLEMENTED</p><p>   * CATABASIS PHARMACEUTICALS - CURRENTLY ESTIMATES TO INCUR CHARGES FOR ONE-TIME TERMINATION BENEFITS IN CONNECTION WITH RESTRUCTURING OF ABOUT $1 MILLION IN Q4</p><p>   * CATABASIS PHARMACEUTICALS SAYS EXPECTS TO COMPLETE THE REDUCTION IN WORKFORCE BY THE END OF THE FOURTH QUARTER OF 2020</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Catabasis Pharmaceuticals Says Board Approved Reduction In Company’S Workforce Of About 48%- SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Catabasis Pharmaceuticals Says Board Approved Reduction In Company’S Workforce Of About 48%- SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2020-12-07 21:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Dec 7 (Reuters) - Catabasis Pharmaceuticals Inc   :</p><p>   * CATABASIS PHARMACEUTICALS SAYS ON DECEMBER 4, BOARD APPROVED REDUCTION IN COMPANY’S WORKFORCE OF ABOUT 48%, TO A TOTAL OF 16 EMPLOYEES - SEC FILING</p><p>   * CATABASIS PHARMACEUTICALS - EXPECTS RESTRUCTURING TO RESULT IN ABOUT $2.8 MILLION IN REDUCED ANNUALIZED WORKFORCE EXPENSES ONCE PLAN FULLY IMPLEMENTED</p><p>   * CATABASIS PHARMACEUTICALS - CURRENTLY ESTIMATES TO INCUR CHARGES FOR ONE-TIME TERMINATION BENEFITS IN CONNECTION WITH RESTRUCTURING OF ABOUT $1 MILLION IN Q4</p><p>   * CATABASIS PHARMACEUTICALS SAYS EXPECTS TO COMPLETE THE REDUCTION IN WORKFORCE BY THE END OF THE FOURTH QUARTER OF 2020</p><p>Source text for Eikon: [ Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2089011144","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2089011144","pubTimestamp":1607348956,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Dec 7 (Reuters) - Catabasis Pharmaceuticals Inc   :   * CATABASIS PHARMACEUTICALS SAYS ON DECEMBER 4","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"BRIEF-Catabasis Pharmaceuticals称董事会批准公司裁员约48%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CATB":0.9},"content_text":"Dec 7 (Reuters) - Catabasis Pharmaceuticals Inc   :   * CATABASIS PHARMACEUTICALS SAYS ON DECEMBER 4, BOARD APPROVED REDUCTION IN COMPANY’S WORKFORCE OF ABOUT 48%, TO A TOTAL OF 16 EMPLOYEES - SEC FILING   * CATABASIS PHARMACEUTICALS - EXPECTS RESTRUCTURING TO RESULT IN ABOUT $2.8 MILLION IN REDUCED ANNUALIZED WORKFORCE EXPENSES ONCE PLAN FULLY IMPLEMENTED   * CATABASIS PHARMACEUTICALS - CURRENTLY ESTIMATES TO INCUR CHARGES FOR ONE-TIME TERMINATION BENEFITS IN CONNECTION WITH RESTRUCTURING OF ABOUT $1 MILLION IN Q4   * CATABASIS PHARMACEUTICALS SAYS EXPECTS TO COMPLETE THE REDUCTION IN WORKFORCE BY THE END OF THE FOURTH QUARTER OF 2020Source text for Eikon: [ Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}